Emergent BioSolutions Gains After Analyst Actions
Emergent BioSolutions Inc. (EBS) shares are gaining more than 10 percent on Monday morning after Analyst Robert Wasserman raised the rating from Hold to Buy with price target of $22.
Source: rttnews.com